This Huge Canadian Cannabis Player Just Got Bigger

Here’s why Canopy Growth Corp. (TSX:WEED)(NYSE:CGC) should be on watch, as the company makes a deal to expand its Canadian presence.

Canopy Growth (TSX: WEED)(NYSE:CGC) had gotten off to an impressive start in 2021. From Jan. 1 through mid-February, shares of Canopy doubled. That’s not bad for a six-week return.

However, since then, shares have traded to the downside, giving up nearly all their gains from earlier this year. Today, shareholders can pick up Canopy Growth at what many growth investors may consider to be a good entry point.

Among the reasons for this optimism is Canopy’s growth trajectory. The company remains one of the largest cannabis companies in Canada. It’s growing both organically, and via acquisition. And today, there’s a considerable amount of excitement around growth in latter department.

Let’s dive into one deal I think investors should have their eye on right now.

Latest acquisition: Another jewel in Canopy’s crown?

Canopy recently announced a $435 million acquisition of Toronto-based Supreme Cannabis (TSX:FIRE). This deal has been widely touted as a positive one among investors bullish on Canopy’s consolidation of the domestic recreational pot market.

Supreme is one of the bigger players in recreational cannabis in Canada. Accordingly, this move appears to be a bullish one for investors banking on continued growth in Canada’s recreational cannabis market.

Indeed, Canada’s recreational cannabis market has grown considerably over the past year. The country’s adoption of cannabis was slow at the start but has begun to pick up steam of late. If Canopy can indeed eat away at domestic market share and improve its margins, investors may really like this deal a few years down the road.

Supreme’s value is that it’s one of the few players with positive adjusted EBITDA numbers in recent quarters. The company’s making steps to become profitable, and revenue continues to increase at a rapid rate. Canopy is clearly looking for deals that positively impact its top and bottom lines. In this regard, it appears Canopy shareholders have a lot to like about this deal.

U.S. cannabis market still the target investors are chasing

That said, this deal still focuses primarily on the Canadian market.

Investors bullish on U.S. legalization may not benefit from this deal all that much. Canopy has made inroads into the U.S. market in some respects. However, like most Canadian players, right now, Canopy is locked out of the lucrative THC market south of the border. Until regulation comes into play, and cross-border THC sales become possible, this will remain the norm across the sector.

Accordingly, investors in Canopy are still largely focused on how the company’s performing domestically. This Supreme deal could boost the company’s position in the Canadian market meaningfully.

That said, I remain cautious on most Canadian cannabis names right now. The U.S. is the market investors will want to chase from here. Accordingly, I’m on the sidelines with respect to companies like Canopy right now.

Fool contributor Chris MacDonald has no position in any of the stocks mentioned.

More on Cannabis Stocks

Medicinal research is conducted on cannabis.
Cannabis Stocks

Top Canadian Stocks to Buy Right Now With $1,000

Cannara, Source Energy and CareRx just updated investors. See what $1,000 can buy in these Canadian stocks, plus the risks…

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Stocks for Beginners

This Cannabis Stock Jumped 12% in a Day: The Math Says Be Careful

Tilray's record revenue came with declining cannabis sales and negative free cash flow, making the investment much more speculative than…

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Curaleaf’s Takeover Bid for Aurora Cannabis: What Investors Need to Know

Curaleaf's takeover bid for Aurora Cannabis offers a premium but brings stock, debt, and deal risks. Here’s what ACB investors…

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Curaleaf Just Announced a Hostile Takeover Bid for Aurora Cannabis. Here’s What This Means for Investors.

It's appealing directly to the Canadian company's shareholders with a cash-and-stock offer.

Read more »

runner checks her biodata on smartwatch
Cannabis Stocks

Average TFSA and RRSP Balances at Age 45: Are You on Par?

Most 45-year-olds have less than $100,000 combined in their TFSA and RRSP. Here's how TerrAscend could help you close the…

Read more »

Yellow caution tape attached to traffic cone
Cannabis Stocks

2 Risky Stocks That Could Send Your $100,000 Investment to $0

Cannabis stocks look risky because price wars, dilution, and regulation can turn one weak quarter into a long drawdown.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

My Biggest Investing Regret in 2025 Was Buying This Stock

Canopy Growth is a cautionary reminder to buy businesses, not headlines, especially in hype-driven sectors like cannabis.

Read more »

Yellow caution tape attached to traffic cone
Cannabis Stocks

2 Popular Stocks That Could Wipe Out a $100,000 Nest Egg

Aurora Cannabis (TSX:ACB) is one stock that could wipe out your nest egg.

Read more »